Osteosarcoma - Bone Cancer Treatment
You or a loved one have been diagnosed with osteosarcoma? Osteosarcoma in Tunisia is a malignant bone cancer that requires rapid and multidisciplinary management. In Tunisia, specialized orthopedists and oncologists provide comprehensive treatment (surgery, chemotherapy) at competitive prices.
What is osteosarcoma?
Osteosarcoma is a malignant bone cancer that develops from osteoblasts, the cells responsible for bone formation. It is the most common primary bone cancer in children, adolescents and young adults (peak incidence between 10 and 20 years). Osteosarcoma can affect any bone, but is most often located in the long bones of the lower limbs (femur, tibia) and upper limbs (humerus), as well as the pelvis. It is an aggressive tumor that can spread (metastasize) to the lungs.
Causes of osteosarcoma
The exact causes of osteosarcoma are not fully understood. Age is an important factor in growing adolescents. Genetic mutations increase the risk. Exposure to ionizing radiation is a risk factor. Pre-existing bone diseases are associated. Excessive physical activity during childhood may play a role. Family predisposition is rare but possible.
Symptoms of osteosarcoma
Symptoms of osteosarcoma can be insidious at first. Bone pain is the most common symptom, often intermittent then continuous. Swelling and a palpable mass may appear. Pathological fracture may reveal the diagnosis. Limping may occur if the tumor is located in the lower limb. Fever and fatigue are possible. Unexplained weight loss may be present. Symptoms can evolve over several weeks or months.
Diagnosis of osteosarcoma
Diagnosis of osteosarcoma is based on several examinations. X-rays show an osteolytic lesion with a "sunburst" appearance. CT scan and MRI specify local tumor extension. Bone scintigraphy and PET scan look for metastases. Bone biopsy is the reference examination to confirm the diagnosis. Pathological analysis determines the type and grade of osteosarcoma. Biological assessment is performed.
Treatment of osteosarcoma
Treatment of osteosarcoma is multidisciplinary. It is based on a combination of therapies. Chemotherapy is administered before and after surgery. Surgery is the local reference treatment. It consists of resection of the tumor with a safety margin. Bone reconstruction is performed by prosthesis or graft. Radiotherapy is sometimes used for inoperable tumors. Treatment choice depends on the location and extension of the tumor.
Osteosarcoma surgery
Surgery is the key step in osteosarcoma treatment. Surgical excision removes the tumor with a margin of healthy tissue. Bone reconstruction restores limb function. Several techniques exist: massive prosthesis or bone graft. Limb salvage is the most common technique. Amputation is reserved for tumors that are too extensive. Surgery is performed under general anesthesia and lasts 3 to 6 hours. Hospitalization is 5 to 10 days. Rehabilitation is essential after the procedure.
Post-operative recovery
Post-operative recovery after osteosarcoma surgery is complex and progressive. Post-operative pain is controlled with painkillers. Monitoring is provided to detect complications such as infection. Rehabilitation begins early to prevent stiffness. Walking is gradually resumed with assistive devices. Return to daily activities is progressive after 2 to 4 weeks. Sutures are removed in 10 to 14 days. Return to work depends on the nature of the professional activity. It can take 3 to 6 months.
Treatment results
Treatment results for osteosarcoma have improved significantly. The 5-year survival rate is 60 to 70% for localized forms. Survival rate is higher in good responders to chemotherapy. The risk of recurrence is 30 to 40% within 5 years. Quality of life is improved thanks to limb-sparing surgery. Regular follow-up is essential to detect any recurrence or metastases early.
Risks and complications
Osteosarcoma management carries risks, although rare. Infection may occur around the prosthesis. Venous thrombosis is possible. Prosthesis fracture may occur. Non-union is a risk. Limb length inequality is possible. Joint stiffness may occur. Chemotherapy side effects are common. Recurrence or metastases are possible. Choosing an experienced multidisciplinary team minimizes these risks.
What is the price of osteosarcoma treatment in Tunisia?
Tunisia offers very competitive prices for osteosarcoma treatment. Diagnostic bone biopsy costs between €1,000 and €1,500. Tumor resection surgery of a lower limb is priced from €8,000 to €12,000. Resection of an upper limb ranges from €7,000 to €10,000. Prosthetic reconstruction is offered from €4,000 to €8,000. A cycle of neoadjuvant chemotherapy costs from €3,000 to €5,000. A complete package is established on a personalized quote. These prices are up to 50 to 60% cheaper than in Europe, without compromising on quality.
Frequently Asked Questions about Osteosarcoma
1Is osteosarcoma hereditary?
Osteosarcoma is generally not hereditary in the majority of cases. However, certain rare genetic mutations (such as TP53 gene mutation or hereditary retinoblastoma) can increase the risk. Family history of osteosarcoma is rare and does not justify systematic screening.
2What is the hospitalization duration for osteosarcoma?
The hospitalization duration for osteosarcoma varies depending on the treatment. For tumor resection surgery, hospitalization is 5 to 10 days. Chemotherapy cycles require hospitalization of 2 to 5 days per cycle. Total treatment duration spans several months.
3Can osteosarcoma recur after treatment?
The risk of osteosarcoma recurrence is about 30 to 40% within 5 years of treatment. Recurrences most often occur within the first 2 to 3 years. Regular follow-up (imaging, consultations) is essential to detect any recurrence early.
4What is the difference between osteosarcoma and a benign tumor?
Osteosarcoma is a malignant (cancerous) tumor that can spread to other organs (metastases). Benign tumors (osteoid osteoma, osteoblastoma) are non-cancerous, do not spread and have an excellent prognosis. Osteosarcoma requires aggressive treatment (surgery + chemotherapy).
5Is chemotherapy always necessary for osteosarcoma?
Yes, chemotherapy is an essential part of osteosarcoma treatment. It is administered before surgery (neoadjuvant chemotherapy) to reduce the tumor and after surgery (adjuvant chemotherapy) to eliminate residual cancer cells. Chemotherapy significantly improves cure rates.
6When can I resume sports after osteosarcoma?
Returning to sports after osteosarcoma depends on the location of the tumor and the type of bone reconstruction. A gradual return is generally possible after 6 to 12 months, subject to satisfactory bone consolidation and medical advice. Impact sports are often discouraged.
7Can osteosarcoma affect adults?
Yes, osteosarcoma can affect adults, although it is more common in adolescents and young adults (peak incidence between 10 and 20 years). In adults, osteosarcoma is often associated with risk factors such as Paget's disease or a history of radiotherapy.
Why choose Tunisia for your osteosarcoma treatment?
Tunisia has reference centers in orthopedic oncology. Multidisciplinary teams work there, including orthopedists, oncologists and radiotherapists. Tunisian orthopedic surgeons are trained in the best European centers. They master tumor resection and reconstruction techniques. Modern technical platforms include MRI, CT scan and PET scan. Prices are competitive with significant savings. Care is prompt and personalized. Tunisia offers a pleasant setting for recovery.
In Conclusion
Osteosarcoma is an aggressive bone cancer that requires rapid and multidisciplinary management. Tunisie Esthetic offers you access to quality care, provided by specialized orthopedists and oncologists, in modern facilities and at competitive prices. Feel free to contact us to discuss your situation and obtain a personalized quote.